A Forecasting Model of Disease Prevalence Based on the McKendrick-von Foerster Equation

Overview

Journal Math Biosci

Specialty Public Health

Date 2019 Jan 1

PMID 30597156

Citations 5

Authors

I Akushevich

A Yashkin

J Kravchenko

F Fang

K Arbeev

F Sloan

A I Yashin

Affiliations

Soon will be listed here.

Abstract

A new model for disease prevalence based on the analytical solutions of McKendric-von Foerster's partial differential equations is developed. Derivation of the model and methods to cross check obtained results are explicitly demonstrated. Obtained equations describe the time evolution of the healthy and unhealthy age-structured sub-populations and age patterns of disease prevalence. The projection of disease prevalence into the future requires estimates of time trends of age-specific disease incidence, relative survival functions, and prevalence at the initial age and year available in the data. The computational scheme for parameter estimations using Medicare data, analytical properties of the model, application for diabetes prevalence, and relationship with partitioning models are described and discussed. The model allows natural generalization for the case of several diseases as well as for modeling time trends in cause-specific mortality rates.

Citing Articles

Dynamic mirroring: unveiling the role of digital twins, artificial intelligence and synthetic data for personalized medicine in laboratory medicine.

Padoan A, Plebani M Clin Chem Lab Med. 2024; 62(11):2156-2161.

PMID: 38726708 DOI: 10.1515/cclm-2024-0517.

Forecasting prevalence and mortality of Alzheimer's disease using the partitioning models.

Akushevich I, Yashkin A, Kovtun M, Kravchenko J, Arbeev K, Yashin A Exp Gerontol. 2023; 174:112133.

PMID: 36842469 PMC: 10103071. DOI: 10.1016/j.exger.2023.112133.

Geographic disparities in mortality from Alzheimer's disease and related dementias.

Akushevich I, Yashkin A, Yashin A, Kravchenko J J Am Geriatr Soc. 2021; 69(8):2306-2315.

PMID: 34009643 PMC: 8373784. DOI: 10.1111/jgs.17215.

Partitioning of time trends in prevalence and mortality of bladder cancer in the United States.

Akushevich I, Yashkin A, Inman B, Sloan F Ann Epidemiol. 2020; 47:25-29.

PMID: 32713504 PMC: 7385284. DOI: 10.1016/j.annepidem.2020.05.006.

Partitioning of time trends in prevalence and mortality of lung cancer.

Akushevich I, Kravchenko J, Yashkin A, Fang F, Yashin A Stat Med. 2019; 38(17):3184-3203.

PMID: 31087384 PMC: 8447842. DOI: 10.1002/sim.8170.

References

Hebert L, Weuve J, Scherr P, Evans D . Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology. 2013; 80(19):1778-83. PMC: 3719424. DOI: 10.1212/WNL.0b013e31828726f5. View

Guariguata L, Whiting D, Hambleton I, Beagley J, Linnenkamp U, Shaw J . Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014; 103(2):137-49. DOI: 10.1016/j.diabres.2013.11.002. View

Akushevich I, Kravchenko J, Ukraintseva S, Arbeev K, Yashin A . Recovery and survival from aging-associated diseases. Exp Gerontol. 2013; 48(8):824-30. PMC: 3723111. DOI: 10.1016/j.exger.2013.05.056. View

Boyle J, Thompson T, Gregg E, Barker L, Williamson D . Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010; 8:29. PMC: 2984379. DOI: 10.1186/1478-7954-8-29. View

Narayan K, Boyle J, Geiss L, Saaddine J, Thompson T . Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care. 2006; 29(9):2114-6. DOI: 10.2337/dc06-1136. View

Miyasaka Y, Barnes M, Gersh B, Cha S, Bailey K, Abhayaratna W . Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006; 114(2):119-25. DOI: 10.1161/CIRCULATIONAHA.105.595140. View

Akushevich I, Yashkin A, Kravchenko J, Fang F, Arbeev K, Sloan F . Theory of partitioning of disease prevalence and mortality in observational data. Theor Popul Biol. 2017; 114:117-127. PMC: 5459580. DOI: 10.1016/j.tpb.2017.01.003. View

Honeycutt A, Boyle J, Broglio K, Thompson T, Hoerger T, Geiss L . A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health Care Manag Sci. 2003; 6(3):155-64. DOI: 10.1023/a:1024467522972. View

Boyle J, Honeycutt A, Narayan K, Hoerger T, Geiss L, Chen H . Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care. 2001; 24(11):1936-40. DOI: 10.2337/diacare.24.11.1936. View

10.

Tham Y, Li X, Wong T, Quigley H, Aung T, Cheng C . Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121(11):2081-90. DOI: 10.1016/j.ophtha.2014.05.013. View

11.

Xue J, Ma J, Louis T, Collins A . Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol. 2001; 12(12):2753-2758. DOI: 10.1681/ASN.V12122753. View

12.

Naccarelli G, Varker H, Lin J, Schulman K . Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009; 104(11):1534-9. DOI: 10.1016/j.amjcard.2009.07.022. View

13.

King H, Aubert R, Herman W . Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21(9):1414-31. DOI: 10.2337/diacare.21.9.1414. View